PENIS CARCINOMA RECURRENT

PENIS CARCINOMA RECURRENT was reported 5 times

PENIS CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
1 BCL-2 Inhibitor [EPC] 1 0.0000
2 Platinum-based Drug [EPC] 3 0.0000
3 Alkylating Drug [EPC] 2 0.0000
4 Leukocyte Growth Factor [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
7 Insulin Analog [EPC] 1 0.0000
8 Platelet Aggregation Inhibitor [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000